Athena Pharmaceutiques S.A.S.

Athena Pharmaceutiques S.A.S. is a pharmaceutical company that focuses on the development, manufacturing, and licensing of oral solid dosage forms. Established in 2011, the company's mission, as reflected in its slogan "To be a Partner of Choice for Life Cycle Management," is to be a leading partner for life cycle management in the pharmaceutical industry.

Athena Pharmaceutiques has demonstrated a decade-long dedication to developing innovative life cycle products, with a focus on modified-release formulations. The company has developed a diverse range of technology platforms for oral delivery, resulting in a wide array of products spanning therapeutic areas including pain management, central nervous system disorders, cardiovascular diseases, diabetes, orphan drugs, corticosteroids, gynecology, and gastroenterology.

Currently, specific information about the company's headquarters, last investment, and last investment's investors is unavailable. However, given Athena Pharmaceutiques' innovative approach and extensive product portfolio, it presents an intriguing opportunity for potential venture capital investment within the pharmaceutical industry.